Take Homes in Lung Cancer

Take Homes in Lung Cancer

Source: Healio Interview
Disclosures: Winkfield reports consulting for AstraZeneca, Bristol-Myers Squibb, Grail Bio, Inc., Merck and NIH: Inclusive Participation COVID-19; and receiving honoraria from BioAscend and Pfizer/AONN.
November 23, 2021
1 min watch
Save

VIDEO: Precision medicine in cancer care needs to ‘meet patients where they are’

Source: Healio Interview
Disclosures: Winkfield reports consulting for AstraZeneca, Bristol-Myers Squibb, Grail Bio, Inc., Merck and NIH: Inclusive Participation COVID-19; and receiving honoraria from BioAscend and Pfizer/AONN.
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Karen M. Winkfield, MD, PhD, spoke with Healio about a lecture on precision medicine she gave at this year’s Chemotherapy Foundation Symposium.

“We need to be meeting the patient where they are,” said Winkfield, executive director of the Meharry-Vanderbilt Alliance, Ingram Professor of cancer research and professor of radiation oncology at Vanderbilt University. “Can we actually be precise in the way that we are delivering medicine in a holistic way?”

References:

  • Winkfield KM. Greenspan Lecture: Precision Medicine Ensuring Every Patient Gets the Right Treatment at the Right Time. Presented at: Chemotherapy Foundation Symposium; Nov. 3-5, 2021.